| Literature DB >> 31620299 |
Na-Young Ha1, Dae Hwan Kim1, Ji Young Ryu1.
Abstract
BACKGROUND: 5-chloro-2-(2,4-dichlorophenoxy)phenol (triclosan) is used as an antiseptic and is a potential endocrine-disrupting chemical that can affect thyroid hormone levels. This study evaluated the relationship between triclosan exposure and thyroid hormones.Entities:
Keywords: Endocrine-disrupting chemical; Thyroid hormone; Triclosan
Year: 2019 PMID: 31620299 PMCID: PMC6779949 DOI: 10.35371/aoem.2019.31.e22
Source DB: PubMed Journal: Ann Occup Environ Med ISSN: 2052-4374
Distribution of serum thyroid hormone levels and urinary triclosan concentrations among the participants (n = 5,990)
| Variable | % < LOD* | GM | Percentile | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5th | 10th | 25th | 50th | 75th | 90th | 95th | ||||
| Total T3 (ng/dL) | 0.0% | |||||||||
| Total | 98.55 | 74.00 | 79.00 | 87.00 | 99.00 | 111.00 | 124.00 | 132.00 | ||
| Male | 101.63 | 76.00 | 81.00 | 90.00 | 102.00 | 114.00 | 127.00 | 136.00 | ||
| Female | 96.22 | 73.00 | 78.00 | 86.00 | 96.00 | 108.00 | 120.00 | 128.00 | ||
| Total T4 (µg/dL) | 0.0% | |||||||||
| Total | 7.95 | 5.70 | 6.30 | 7.10 | 8.10 | 9.00 | 9.90 | 10.40 | ||
| Male | 7.93 | 5.60 | 6.20 | 7.10 | 8.10 | 9.00 | 9.89 | 10.40 | ||
| Female | 7.96 | 5.70 | 6.30 | 7.20 | 8.10 | 9.00 | 9.90 | 10.40 | ||
| TSH (µIU/mL) | 0.0% | |||||||||
| Total | 1.93 | 0.66 | 0.86 | 1.29 | 1.95 | 2.92 | 4.29 | 5.43 | ||
| Male | 1.81 | 0.64 | 0.81 | 1.20 | 1.83 | 2.74 | 3.96 | 4.92 | ||
| Female | 2.03 | 0.69 | 0.91 | 1.36 | 2.04 | 3.05 | 4.56 | 5.77 | ||
| Triclosan (µg/L) | ||||||||||
| Total | 59.6% | NC | - | - | - | - | 1.21 | 7.89 | 41.73 | |
| Male | 61.6% | NC | - | - | - | - | 1.10 | 6.37 | 41.29 | |
| Female | 58.1% | NC | - | - | - | - | 1.34 | 9.25 | 42.89 | |
LOD: limit of detection; GM: geometric mean; T3: triiodothyronine; T4: thyroxine; TSH: thyroid-stimulating hormone; Triclosan: 5-chloro-2-(2,4-dichlorophenoxy)phenol; NC: not calculated; -, below limit of detection.
*LOD = 0.5 μg/L.
Geometric mean with 95% CI of serum thyroid hormone levels and percentage for urinary triclosan above the detection limit by demographic characteristics
| Variable | Category | No. (weighted %) | Total T3 (ng/dL) | Total T4 (µg/dL) | TSH (µIU/mL) | Triclosan detected* | |||
|---|---|---|---|---|---|---|---|---|---|
| Unweighted GM (95% CI) | Weighted GM (95% CI) | Unweighted GM (95% CI) | Weighted GM (95% CI) | Unweighted GM (95% CI) | Weighted GM (95% CI) | No. (weighted %) | |||
| Sex | Male | 2,630 (50.3) | 101.63 (100.93–102.32) | 102.08 (100.91–103.28) | 7.93 (7.88–7.99) | 7.96 (7.88–8.04) | 1.81 (1.76–1.85) | 1.77 (1.72–1.82) | 1,010 (41.5) |
| Female | 3,360 (49.7) | 96.22 (95.65–96.79) | 95.62 (94.60–96.64) | 7.96 (7.91–8.01) | 7.96 (7.88–8.04) | 2.03 (1.98–2.07) | 1.96 (1.91–2.02) | 1,409 (43.9) | |
| < 0.001 | < 0.001 | 0.534 | 0.991 | < 0.001 | < 0.001 | 0.158 | |||
| Age (years) | 19–29 | 499 (17.7) | 98.36 (96.88–99.84)‡ | 98.35 (96.38–100.35) | 8.01 (7.88–8.15) | 7.98 (7.82–8.14) | 1.53 (1.46–1.62)† | 1.53 (1.45–1.62)† | 255 (49.4) |
| 30–39 | 981 (20.0) | 98.06 (96.95–99.19)‡ | 99.13 (97.43–100.87) | 7.93 (7.84–8.01) | 7.97 (7.85–8.09) | 1.82 (1.75–1.88)‡ | 1.77 (1.69–1.85)‡ | 422 (43.8) | |
| 40–49 | 1,153 (21.5) | 98.47 (97.50–99.46)‡ | 98.35 (96.71–100.00) | 7.94 (7.86–8.02) | 7.96 (7.84–8.07) | 1.97 (1.90–2.04)§ | 1.94 (1.86–2.02)§ | 508 (45.1) | |
| 50–59 | 1,325 (19.3) | 99.49 (98.53–100.47)‡ | 100.33 (98.95–101.74) | 7.90 (7.82–7.98) | 7.92 (7.81–8.03) | 2.04 (1.97–2.12)§ | 2.03 (1.93–2.13)§ | 549 (42.9) | |
| 60–69 | 1,232 (11.0) | 99.67 (98.67–100.69)‡ | 98.98 (97.43–100.55) | 7.99 (7.90–8.08) | 7.95 (7.83–8.07) | 2.00 (1.93–2.08)§ | 2.05 (1.95–2.15)§ | 435 (35.5) | |
| ≥ 70 | 800 (10.4) | 96.14 (94.94–97.36)† | 97.03 (95.28–98.81) | 7.94 (7.83–8.04) | 7.98 (7.84–8.12) | 1.98 (1.88–2.08)§ | 2.05 (1.92–2.18)§ | 250 (31.6) | |
| < 0.001 | 0.073 | 0.629 | 0.985 | < 0.001 | < 0.001 | < 0.001 | |||
| 0.331 | 0.794 | 0.616 | 0.766 | < 0.001 | < 0.001 | ||||
| BMI (kg/m2) | < 18.50 | 142 (3.0) | 93.51 (90.41–96.72)† | 93.07 (89.26–97.04)† | 8.01 (7.75–8.28) | 8.19 (7.88–8.51) | 1.58 (1.42–1.75)† | 1.44 (1.26–1.63)† | 58 (40.9) |
| 18.50–22.99 | 2,040 (36.4) | 95.51 (94.77–96.24)† | 95.71 (94.57–96.85)† | 7.95 (7.89–8.01) | 7.93 (7.83–8.02) | 1.84 (1.79–1.90)‡ | 1.80 (1.74–1.86)‡ | 832 (42.4) | |
| 23.00–24.99 | 1,491 (23.1) | 98.67 (97.81–99.53)‡ | 99.08 (97.72–100.45)‡ | 7.89 (7.82–7.97) | 7.90 (7.79–8.01) | 1.96 (1.90–2.03)‡ | 1.86 (1.79–1.93)‡ | 606 (43.3) | |
| ≥ 25.00 | 2,317 (37.5) | 101.57 (100.83–102.31)§ | 102.26 (101.00–103.53)§ | 7.97 (7.91–8.03) | 8.01 (7.92–8.10) | 2.00 (1.95–2.06)‡ | 1.97 (1.91–2.04)§ | 923 (42.8) | |
| < 0.001 | < 0.001 | 0.403 | 0.088 | < 0.001 | < 0.001 | 0.962 | |||
| < 0.001 | < 0.001 | 0.656 | 0.480 | < 0.001 | < 0.001 | ||||
| Smoking status | Smoker | 1,090 (22.0) | 104.19 (103.06–105.33) | 104.57 (102.87–106.31) | 8.09 (8.00–8.18) | 8.10 (7.98–8.21) | 1.60 (1.54–1.65) | 1.60 (1.53–1.67) | 408 (40.7) |
| Current non-smoker | 4,900 (78.0) | 97.34 (96.86–97.82) | 97.25 (96.27–98.23) | 7.91 (7.87–7.95) | 7.92 (7.84–7.99) | 2.01 (1.97–2.05) | 1.95 (1.90–1.99) | 2,011 (43.3) | |
| < 0.001 | < 0.001 | < 0.001 | 0.003 | < 0.001 | < 0.001 | 0.230 | |||
| Total | 5,990 (100) | 98.55 (98.11–99.00) | 98.82 (97.83–99.81) | 7.95 (7.91–7.98) | 7.96 (7.89–8.03) | 1.93 (1.89–1.96) | 1.86 (1.83–1.90) | 2,419 (42.7) | |
BMI: body mass index; T3: triiodothyronine; T4: thyroxine; TSH: thyroid-stimulating hormone; Triclosan: 5-chloro-2-(2,4-dichlorophenoxy)phenol; GM: geometric mean; CI: confidence interval; LOD: limit of detection.
*Sample size and weighted percentage for urinary triclosan above the detection limit (≥ LOD, 0.5 μg/L); Post hoc analysis († < ‡ < §).
Weighted adjusted* regression coefficients and estimated mean with 95% CI between serum thyroid hormones and triclosan exposure group†
| Triclosan exposure group | ln total T3 (ng/dL) | Total T3 (ng/dL) | ln total T4 (µg/dL) | Total T4 (µg/dL) | ln TSH (µIU/mL) | TSH (µIU/mL) | |
|---|---|---|---|---|---|---|---|
| β (95% CI) | Estimated mean (95% CI) | β (95% CI) | Estimated mean (95% CI) | β (95% CI) | Estimated mean (95% CI) | ||
| Male | |||||||
| Detected (≥ LOD‡) | 0.000 (−0.019, 0.018) | 103.11 (101.36, 104.88) | −0.011 (−0.033, 0.010) | 7.95 (7.82, 8.08) | 0.028 (−0.035, 0.091) | 1.76 (1.68, 1.85) | |
| Below detection (< LOD) | 0 (reference) | 103.13 (101.85, 104.43) | 0 (reference) | 8.04 (7.94, 8.15) | 0 (reference) | 1.71 (1.65, 1.78) | |
| 0.984 | 0.298 | 0.379 | |||||
| Female | |||||||
| Detected (≥ LOD) | −0.010 (−0.028, 0.007) | 94.79 (92.02, 97.64) | −0.010 (−0.028, 0.008) | 7.93 (7.70, 8.16) | 0.066 (−0.002, 0.134) | 1.86 (1.71, 2.02) | |
| Below detection (< LOD) | 0 (reference) | 95.78 (92.82, 98.84) | 0 (reference) | 8.01 (7.80, 8.22) | 0 (reference) | 1.74 (1.60, 1.89) | |
| 0.251 | 0.288 | 0.058 | |||||
T3: triiodothyronine; T4: thyroxine; TSH: thyroid-stimulating hormone; Triclosan: 5-chloro-2-(2,4-dichlorophenoxy)phenol; CI: confidence interval; LOD: limit of detection.
*Adjusted for age, body mass index, urinary creatinine, and smoking status; †Coded as a dichotomous variable, regression coefficient represents change in serum thyroid measure in relation to having a detectable urinary triclosan concentration; ‡LOD = 0.5 μg/L.